| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1567-5688(09)71806-9 |
| P698 | PubMed publication ID | 20129370 |
| P50 | author | Stefan R. Bornstein | Q17126504 |
| P2093 | author name string | Gerd Schmitz | |
| Andreas Barthel | |||
| Ulrich Julius | |||
| Sergey Tselmin | |||
| Juergen Graessler | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients | Q28475747 | ||
| THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 | ||
| Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study | Q30829796 | ||
| Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia | Q31918358 | ||
| Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events | Q34658104 | ||
| A systematic review of LDL apheresis in the treatment of cardiovascular disease | Q36424822 | ||
| Comparison of different LDL apheresis methods | Q37176428 | ||
| Sex hormone binding globulin and aging | Q37310311 | ||
| Lipid composition of human serum lipoproteins | Q39275507 | ||
| Quantification of sphingosine and sphinganine from crude lipid extracts by HPLC electrospray ionization tandem mass spectrometry | Q44535880 | ||
| Abdominal adipose tissue: early metabolic dysfunction associated to insulin resistance and oxidative stress induced by an unbalanced diet | Q44959931 | ||
| High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm | Q45136777 | ||
| Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry | Q46334122 | ||
| Effects of fructose and/or fat in the diet on developing the type 2 diabetic-like syndrome in CD-1 mice | Q46339775 | ||
| Mass spectrometric analysis of lipid species of human circulating blood cells | Q46414128 | ||
| Dietary fat influences testosterone, cholesterol, aminopeptidase A, and blood pressure in male rats | Q46544429 | ||
| Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes | Q46576880 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. | Q51476537 | ||
| Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. | Q54075974 | ||
| Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis | Q68040549 | ||
| Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin-induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia | Q73315264 | ||
| C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis | Q74587104 | ||
| Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group | Q77750545 | ||
| Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis | Q77924171 | ||
| Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis | Q78044117 | ||
| Heparin-mediated extracorporeal LDL precipitation treating a peripheral arterial disease patient suffering from repeated postoperative bypass occlusion | Q81066523 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 27-33 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Atherosclerosis. Supplements | Q27714892 |
| P1476 | title | Acute effects of lipid apheresis on human serum lipidome | |
| P478 | volume | 10 |
| Q64057248 | An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases |
| Q90598631 | Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation |
| Q37686730 | Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors |
| Q55652029 | LDL-apheresis: technical and clinical aspects. |
| Q37738349 | Lipidomics as a tool for the study of lipoprotein metabolism |
| Q38095647 | Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease |
| Q53112915 | Why an apheresis center should offer more than one lipoprotein apheresis method. |
Search more.